FDA Inspection
Guangzhou Hanpu Pharmaceutical Co. Ltd.Guangzhou Hanpu Pharmaceutical Co. Ltd. – FDA Inspection, Jan 25, 2018
Record Details
This FDA Inspection record concerns Guangzhou Hanpu Pharmaceutical Co. Ltd., with an inspection on January 25, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- Person
- Meisha R. Sampson (Issuing Officer)
View Company Profile
ID · d4994f8c-1692-4e93-8724-ee9e297c2f38
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1040600
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Guangzhou Hanpu Pharmaceutical Co. Ltd.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| December 13, 2024 | Not classified | Office of Inspections and Investigations | |
| July 19, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Guangzhou Hanpu Pharmaceutical Co. Ltd.
- FDA Inspection 1259306 - 2024-12-13
- FDA Inspection 844182 - 2013-07-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.